142 hedge funds and large institutions have $640M invested in Genmab in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

7.37% more ownership

Funds ownership: 36.4%43.77% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

99% less call options, than puts

Call options by funds: $2K | Put options by funds: $256K

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$256K
Net Calls
Net Calls Change

Top Buyers

1 +$32.6M
2 +$13.9M
3 +$13M
4
BlackRock
BlackRock
New York
+$12.7M
5
Jennison Associates
Jennison Associates
New York
+$12.6M

Top Sellers

1 -$16.7M
2 -$8.86M
3 -$4.09M
4
Artisan Partners
Artisan Partners
Wisconsin
-$3.49M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$897K
52
$891K
53
$849K
54
$823K
55
$811K
56
$748K
57
$746K
58
$682K
59
$681K
60
$666K
61
$663K
62
$617K
63
$560K
64
$551K
65
$527K
66
$491K
67
$453K
68
$423K
69
$407K
70
$400K
71
$378K
72
$325K
73
$320K
74
$314K
75
$304K